BONVIVA

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom

Active ingredients

The drug BONVIVA contains one active pharmaceutical ingredient (API):

1 Ibandronic acid UNII J12U072QL0 - IBANDRONATE SODIUM

Ibandronic acid belongs to the bisphosphonate group of compounds which act specifically on bone. Their selective action on bone tissue is based on the high affinity of bisphosphonates for bone mineral. Bisphosphonates act by inhibiting osteoclast activity, although the precise mechanism is still not clear. In vivo, ibandronic acid prevents experimentally-induced bone destruction caused by cessation of gonadal function, retinoids, tumours or tumour extracts. Read about Ibandronic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BA06	Ibandronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 559118100008817
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00607239, 00607245, 02159124, 02484999, 02512402, 02512425, 03679699, 04113936, 04188584, 04188590, 05485025, 05485031, 05502373, 06089202, 06092693, 06326234, 06458102, 06494380, 06735079, 06786651, 06864983, 07123390, 07507050, 09013352, 10044613, 10535920, 10989822, 11183216, 11566147, 12432609, 15266471, 16706274, 16733288
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.340-11-06, 27.595-1-03-12
Country: EE	Ravimiamet	Identifier(s): 1213209, 1213210, 1364688, 1364699
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 03265003
Country: FR	Base de données publique des médicaments	Identifier(s): 63460631, 68419617
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 102684, 138372, 142881, 198665, 375948, 95450
Country: HK	Department of Health Drug Office	Identifier(s): 54056, 55745
Country: IE	Health Products Regulatory Authority	Identifier(s): 13295, 13985, 13990, 14017, 14021, 14033
Country: IT	Agenzia del Farmaco	Identifier(s): 036899019, 039672011, 044050019, 044424012
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999040F1026, 3999438G1027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004721, 1004722, 1004771, 1027746
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 020M2005, 080M2003
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 79685, 80675
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100140577, 100159134
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66028001
Country: SG	Health Sciences Authority	Identifier(s): 13206P, 13328P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699543091808, 8699543091860, 8699543950013, 8699543950020